AI Analysis AI Analysis of ALZN AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add ALZN to Watchlist?
  • Easy Tracking In The Watchlist
PDF

Red day on Monday for Alzamend Neuro, Inc. stock after losing 0%
(Updated on Jul 06, 2026)

Sell candidate since Jul 01, 2026 Gain 3.57%

No changes to the price of Alzamend Neuro, Inc. stock on the last trading day (Monday, 6th Jul 2026). During the last trading day the stock fluctuated 5.45% from a day low at $1.10 to a day high of $1.16. The price has fallen in 4 of the last 10 days and is down by -4.92% for this period.

The stock lies in the lower part of a very wide and strong rising trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $1.11 is broken, it will firstly indicate a slower rate of rising, but may also be an early warning for a trend shift. Given the current short-term trend, the stock is expected to rise 23.05% during the next 3 months and, with a 90% probability hold a price between $1.36 and $1.72 at the end of this 3-month period.

ALZN Signals & Forecast

There are few to no technical positive signals at the moment. The Alzamend Neuro, Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. On corrections up, there will be some resistance from the lines at $1.18 and $1.17. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Wednesday, June 24, 2026, and so far it has fallen -15.33%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell on the last day without any changes to the price. This does not cause any direct divergence but may be an early warning and a possible "turning point". The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for Alzamend Neuro, Inc. stock

Alzamend Neuro, Inc. finds support from accumulated volume at $1.15 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day, but be aware of low or falling volume as this increases the risk. During the last day, the stock moved $0.0600 between high and low, or 5.45%. For the last week the stock has had daily average volatility of 11.53%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (ALZN) For The Upcoming Trading Day Of Tuesday 7th

For the upcoming trading day on Tuesday, 7th we expect Alzamend Neuro, Inc. to open at $1.14, and during the day (based on 14 day Average True Range), to move between $1.11 and $1.21, which gives a possible trading interval of +/-$0.0972 (+/-8.75%) up or down from last closing price. If Alzamend Neuro, Inc. takes out the full calculated possible swing range there will be an estimated 8.75% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $1.17 (0.86%) than the support at $1.15 (0.86%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Alzamend Neuro, Inc. stock A Buy?

The Alzamend Neuro, Inc. stock holds several negative signals and despite the positive trend, we believe Alzamend Neuro, Inc. will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

Current score: -4.369 Sell Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on July 7, 2026 - $1.14 ( 1.72%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

ALZN Performance

Trading levels for ALZN

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 1.20 3.45%
R2 1.18 1.47%
R1 1.16 0.252%
Price 1.16
S1 1.12 -3.70%
S2 1.10 -4.92%
S3 1.08 -6.90%

Accumulated Volume Support & Resistance Levels

Level Price
R3 1.37 18.10%
R2 1.20 3.45%
R1 1.17 0.86%
Price 1.16
S1 1.15 -0.86%
S2 1.12 -3.45%
S3 1.04 -10.34%

FAQ

What is the symbol for Alzamend Neuro, Inc. Stock and on which exchange is it traded?
The symbol for Alzamend Neuro, Inc. is ALZN and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Alzamend Neuro, Inc. Stock?
The Alzamend Neuro, Inc. stock holds several negative signals and despite the positive trend, we believe Alzamend Neuro, Inc. will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

How to buy Alzamend Neuro, Inc. Stock?
Alzamend Neuro, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Alzamend Neuro, Inc. Stock.

What's the current price of Alzamend Neuro, Inc. Stock?
As of the end of day on the Jul 06, 2026, the price of an Alzamend Neuro, Inc. (ALZN) share was $1.16.

What is the 52-week high and low for Alzamend Neuro, Inc. Stock?
The 52-week high for Alzamend Neuro, Inc. Stock is $3.60 and the 52-week low is $0.85.

What is the market capitalization of Alzamend Neuro, Inc. Stock?
As of the Jul 06, 2026, the market capitalization of Alzamend Neuro, Inc. is 3.642M.

When is the next earnings date for Alzamend Neuro, Inc.?
The upcoming earnings date for Alzamend Neuro, Inc. is Jul 28, 2026.
Click to get the best stock tips daily for free!
ABOUT ALZAMEND NEURO, INC.
Alzamend Neuro
Alzamend Neuro, Inc., an early clinical-stage biopharmaceutical company, focuses on developing various products for the treatment of neurodegenerative diseases and psychiatric disorders. Its pipeline includes AL001, an ionic cocrystal technology delivering a therapeutic combination of lithium, proline, and salicylate for the treatment of Alzheimer's and other neurodegenerative diseases, and psychiatric disorders; and AL002, a method using a mutan...
GOLDEN STAR
Ticker Change Signal Date
SRPT
$17.02
12.69% Jun 29
OSIS
$218.29
1.16% Jun 26
NMRK
$15.02
3.86% Jun 24
TTEK
$28.04
11.09% Jun 23
NESR
$25.07
10.21% Jun 23

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE